A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.
- DOI
- 10.1007/s13555-026-01791-1
- Published
- 2026 Aug
- Container
- Dermatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-026-01791-1,
title = {A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.},
author = {Silverberg JI and Irvine AD and Foley P and Del Rosso J and Puig L and Stein Gold L and Kamata M and Wollenberg A and Hong HC and Chu CY and Binamer Y and Dossenbach M and Casillas M and Gallo G and Akmaz B and Rand K and Chovatiya R},
year = {2026},
journal = {Dermatology and therapy},
doi = {10.1007/s13555-026-01791-1},
url = {https://doi.org/10.1007/s13555-026-01791-1}
}RIS
TY - JOUR TI - A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence. AU - Silverberg JI AU - Irvine AD AU - Foley P AU - Del Rosso J AU - Puig L AU - Stein Gold L AU - Kamata M AU - Wollenberg A AU - Hong HC AU - Chu CY AU - Binamer Y AU - Dossenbach M AU - Casillas M AU - Gallo G AU - Akmaz B AU - Rand K AU - Chovatiya R PY - 2026 JO - Dermatology and therapy DO - 10.1007/s13555-026-01791-1 UR - https://doi.org/10.1007/s13555-026-01791-1 ER -
APA
JI, S., AD, I., P, F., J, D. R., L, P., L, S. G., M, K., A, W., HC, H., CY, C., Y, B., M, D., M, C., G, G., B, A., K, R., & R, C. (2026). A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01791-1
Source records
- pubmed · retrieved 2026-09-26T06:25:21.152Z